U.S. markets closed

Cannara Biotech Inc. (LOVE.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.15500.0000 (0.00%)
At close: 3:57PM EST
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
Previous Close0.1550
Open0.1550
Bid0.1500 x 0
Ask0.1550 x 0
Day's Range0.1500 - 0.1600
52 Week Range0.0700 - 0.1800
Volume1,381,880
Avg. Volume1,548,593
Market Cap114.365M
Beta (5Y Monthly)1.79
PE Ratio (TTM)N/A
EPS (TTM)-0.0180
Earnings DateApr 16, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Cannara Biotech Launches Cannabis Brand Portfolio Now Available in Quebec - Tribal, Nugz, Orchid CBD
      CNW Group

      Cannara Biotech Launches Cannabis Brand Portfolio Now Available in Quebec - Tribal, Nugz, Orchid CBD

      Cannara's three new brands – Tribal, Nugz and Orchid CBDMONTREAL, Feb. 25, 2021 /CNW/ - Cannara Biotech Inc.

    • Cannara Biotech Inc. Reports Q1 2021 Financial Results
      CNW Group

      Cannara Biotech Inc. Reports Q1 2021 Financial Results

      \- Expects to generate revenue from letter of intent with the Société québécoise du cannabis by end of February or early March 2021 -MONTREAL, Jan. 29, 2021 /CNW/ - Cannara Biotech Inc.

    • Cannara Biotech Receives Sales Licence from Health Canada
      PR Newswire

      Cannara Biotech Receives Sales Licence from Health Canada

      Cannara Biotech Inc.("Cannara" or the "Company") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB) is pleased to announce that, through its wholly-owned subsidiary, Cannara Biotech (Quebec) Inc., it has received approval from Health Canada to amend its license to permit the sale of dried cannabis products to provincially authorized distributors and retailers nationwide. As revenue steadily grows over the next 12 months, Cannara expects rapid growth in profitability and cashflow given its lean operating structure and production cost advantage.